2024
Eva-Maria Manz from our group takes on the role of an OTS trainee representative
Today we are very proud to announce that Eva-Maria Manz from our group becomes an OTS trainee representative. Today Eva-Maria presents our latest advances in therapeutic approaches for erythropoietic protoporphyria.
Representatives of the Hall Group at 2nd Swiss RNA Therapeutics Summit in Bern
Prof. Jonathan hall and PhD students from the Hall group attended the 2nd Swiss RNA Therapeutics Summit in Bern. We are very excited to have fruitful discussions at the poster sessions.